4-methyl-2-oxopentanoate

4-methyl-2-oxopentanoate (CAS No.: 816-66-0) is a short-chain keto acid derivative and a key intermediate in the catabolism of the branched-chain amino acid L-leucine, widely studied in metabolic biology and disease modeling. As a biologically active metabolite, it participates in cellular energy metabolism and functions as a nutrient signaling molecule that can stimulate skeletal muscle protein synthesis while concurrently modulating pathways such as mTOR and autophagy. Experimental evidence indicates that this compound perturbs mitochondrial function by reducing the activity of respiratory chain complexes and promoting the generation of reactive oxygen species, thereby contributing to oxidative stress and metabolic dysfunction. It has also been shown to inhibit α-ketoglutarate dehydrogenase activity and act as an oxidative phosphorylation uncoupler, linking it to impaired cellular bioenergetics and neurotoxicity in relevant models. In adipocyte and neuronal systems, it induces endoplasmic reticulum stress, enhances lipid accumulation, and contributes to insulin resistance and cognitive deficits, highlighting its utility in studying metabolic syndrome and neurodegenerative processes. Accumulation of this metabolite is a hallmark of maple syrup urine disease due to defects in branched-chain α-keto acid dehydrogenase, making it a valuable tool for investigating inborn errors of metabolism and associated pathophysiology. In vitro and in vivo studies typically employ concentrations spanning the low micromolar to millimolar range depending on the model system, and its application extends to cell-based assays, animal models of metabolic and neurological disorders, and mechanistic drug discovery efforts targeting mitochondrial dysfunction and amino acid metabolism.